Catalent Boston adds to oral spray drying capacity to support late-stage clinical trials and commercialisation
Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies and flexible manufacturing, has completed a series of upgrades to its large-scale spray drying unit (GEA PSD-4) at its Boston (MA, US) facility